Latest Funding Moves Expand Keytruda Franchise In England
MSD's immunotherapy drug Keytruda is to be made available to thousands more patients with lung cancer or melanoma in England through the Cancer Drugs Fund.
You may also be interested in...
Dengvaxia, the dengue vaccine from Sanofi that was suspended in the Philippines last year, is among six new products to get a recommendation for marketing authorization from the European Medicines Agency this week.
The latest list of marketing authorization applications under review by the European Medicines Agency includes filings for eight new products.
Viela and Roche both now have marketing applications that are being reviewed by the European Medicines Agency. If approved in the EU, their products will compete with Alexion’s blockbuster Soliris.